Skip to main content
 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 14, 2026
Expenses
$360,000
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
Virginia

Official filing document

 Government bodies contacted 7

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 2

Issues related to durable medical equipment including competitive bidding, power wheelchairs, oxygen, non-invasive ventilators, diabetic supplies, negative pressure wound therapy, Medicare audits, trade and sequestration; Issues related to Medicare sequestration paygo relief legislation; Issues related to Medicare titanium/carbon upgrade legislation, and Medicare coverage of seat elevation and standing features; H.R. 2005 - DMEPOS Relief Act of 2025 (issues related to Medicare reimbursement cuts in DME noncompetitive bidding areas); S. 2951 - Competitive Bidding Relief Act (issues related to Medicare reimbursement cuts in DME noncompetitive bidding areas); Issues related to H.R. 1703/S. 247 - Choices for Increased Mobility Act of 2025; Issues related to H.R. 2902/S. 1406 - SOAR Act of 2025; Issues related to S. 4037 - Diabetes Act.

Issues related to tariffs on medical devices.

 Bills named in this filing 7

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem